
Automated compounding of personalized medicine
What they do: Automated compounding system using 3D printing and GMP pharmaceutical inks for personalized, on‑demand medicines
Founded: 2021 (Finland)
Founders / leadership: Charlotta Topelius (CEO) and Niklas Sandler Topelius (CTO)
Employees: ~30
Funding: Total ~USD 12.2M; Seed and debt rounds reported May 27, 2025
Personalized medicine manufacturing and pharmacy compounding
2021
Healthtech / Pharmaceutical manufacturing
≈€6.7M
Reported seed round announced May 27, 2025
≈€1.0M
Reported debt financing announced May 27, 2025
Crunchbase lists earlier seed and pre-seed rounds in 2021–2022
“Backed by institutional and public investors including Lifeline Ventures, the Pharmacy Pension Fund, EIC grant support, Business Finland loans/grants, and seed investors referenced on records”